These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6741429)

  • 41. Signet-ring plasma cell myeloma.
    Grier DD; Robbins K
    Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
    [No Abstract]   [Full Text] [Related]  

  • 42. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple myeloma and secondary plasma cell leukemia.
    Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA
    Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Plasma cell leukemias].
    Bullorsky EO; Venditti J; Shanley C; Rabinovich O; Lajous JR
    Medicina (B Aires); 1987; 47(4):399-402. PubMed ID: 3452731
    [No Abstract]   [Full Text] [Related]  

  • 45. Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
    Morgan TK; Zhao S; Chang KL; Haddix TL; Domanay E; Cornbleet PJ; Arber DA; Natkunam Y
    Am J Clin Pathol; 2006 Oct; 126(4):545-51. PubMed ID: 16938662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple myeloma with two rate complications.
    Chugh SN; Girdhar NK; Chopra JS; Singh U; Mahajan SK; Malhotra KC
    J Indian Med Assoc; 1988 Sep; 86(9):246-8. PubMed ID: 3235845
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma cell leukemia with myelofibrosis.
    Kasahara S; Tsurumi H; Yoshikawa T; Hara T; Shimizu M; Oyama M; Moriwaki H
    J Clin Exp Hematop; 2008 Nov; 48(2):71-3. PubMed ID: 19039200
    [No Abstract]   [Full Text] [Related]  

  • 48. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
    Zhang XG; Bataille R; Widjenes J; Klein B
    Cancer; 1992 Mar; 69(6):1373-6. PubMed ID: 1540875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
    Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
    Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spindle cell lesion in the bone marrow.
    Guzman S; Kitahara S
    Blood; 2018 Sep; 132(10):1085. PubMed ID: 30190353
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma cell leukemia. A clinical study of 13 cases, with a demonstration of small-sized plasma cells.
    Isobe T; Ikeda Y; Imura H; Ohta H
    Nihon Ketsueki Gakkai Zasshi; 1977 Aug; 40(4):529-40. PubMed ID: 920057
    [No Abstract]   [Full Text] [Related]  

  • 52. Nuclear lobulation and cytoplasmic fibrils in leukemic plasma cells.
    Beltran G; Stuckey WJ
    Am J Clin Pathol; 1972 Aug; 58(2):159-64. PubMed ID: 4114839
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma cell leukemia with myelofibrosis.
    Murayama T; Matsui T; Hayashi Y; Taniguchi T; Ito M; Natazuka T; Imoto S; Iwata N; Isobe T; Ito H
    Ann Hematol; 1994 Sep; 69(3):151-2. PubMed ID: 8086511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Numerous Russell bodies and Dutcher bodies in multiple myeloma.
    van Gammeren AJ; Alcala LS; Smolders M; Boersma RS
    Br J Haematol; 2015 Sep; 170(6):743. PubMed ID: 25312850
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma cell leukemia: case report of a rare and aggressive variant of multiple myeloma.
    Jameel A
    J Pak Med Assoc; 2005 Oct; 55(10):452-3. PubMed ID: 16304856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
    Ucci G; Riccardi A; Dörmer P; Danova M; Luoni R; Montecucco CM; Ciotti R; Girino M
    Cell Tissue Kinet; 1987 May; 20(3):311-8. PubMed ID: 3480077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence of phagocytizing plasma cells in malignant plasma cell dyscrasias.
    Kanoh T; Fujii H
    Scand J Haematol; 1986 May; 36(5):480-3. PubMed ID: 3738429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N; Alnounou R; Alzahrani H; Alsharif F
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasmablastic multiple myeloma with Dutcher bodies.
    Jain D; Singh T
    Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.